UBS Group’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

UBS Group’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,540	Closed	-$372K	–	10393
2023 Q1	$372K	Buy	25,540 +21,527	+536%	+$304K	﹤0.01%	4921
2022 Q4	$29.3K	Buy	4,013 +1,062	+36%	+$7.49K	﹤0.01%	7262
2022 Q3	$21K	Buy	2,951 +386	+15%	+$2.88K	﹤0.01%	7366
2022 Q2	$18K	Buy	2,565 +1,806	+238%	+$14.1K	﹤0.01%	7053
2022 Q1	$6K	Buy	+759	New	+$6.85K	﹤0.01%	9046
2021 Q4	–	Sell	-60	Closed	-$1K	–	11037
2021 Q3	$1K	Sell	60 -4,282	-99%	-$48.3K	﹤0.01%	9346
2021 Q2	$53K	Buy	4,342 +4,340	+217,000%	+$53.9K	﹤0.01%	6390
2021 Q1	$0	Buy	+2	New	+$28	﹤0.01%	9683
2020 Q4	–	Sell	-592	Closed	-$7K	–	8936
2020 Q3	$7K	Buy	+592	New	+$6.85K	﹤0.01%	7160

UBS Group's AMYT Position: Q2 2023 in Review

UBS Group sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 25,540 shares — an estimated $372K sold.

UBS Group first reported a position in AMYT in Q3 2020 and held it in 9 quarters. The position peaked at $372K in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

UBS Group reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
UBS Group sold 25,540 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $372K.
UBS Group first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2020 and held it in 9 quarters.
UBS Group's Amryt Pharma plc American Depositary Shares position peaked at $372K in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.